Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter.
about
Effects of Mycotoxins on mucosal microbial infection and related pathogenesisDiagnosis of Irritable Bowel Syndrome: Role of Potential BiomarkersProfile of rifaximin and its potential in the treatment of irritable bowel syndromeNew Weapons to Fight Old Enemies: Novel Strategies for the (Bio)control of Bacterial Biofilms in the Food IndustryGut microbiota as potential orchestrators of irritable bowel syndromeGlobal Epidemiology of Campylobacter InfectionDisruption of the human gut microbiota following Norovirus infectionMulti-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Benefit of the Probiotic Bifidobacterium infantis 35624 in Non-Patients With Symptoms of Abdominal Discomfort and Bloating.Irritable bowel syndrome in children: pathogenesis, diagnosis and evidence-based treatmentIrritable bowel syndrome: a microbiome-gut-brain axis disorder?The second study of infectious intestinal disease (IID2): increased rates of recurrent diarrhoea in individuals aged 65 years and above.Bacterial infections in childhood: A risk factor for gastrointestinal and other diseases?Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)?Risk of Psychiatric Disorders following Irritable Bowel Syndrome: A Nationwide Population-Based Cohort Study.IBS and IBD - separate entities or on a spectrum?Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome.Irritable bowel syndrome: emerging paradigm in pathophysiology.Role of gut pathogens in development of irritable bowel syndrome.On the fiftieth anniversary. Postinfectious irritable bowel syndrome: mechanisms related to pathogens.Systematic review with meta-analysis: post-infectious irritable bowel syndrome after travellers' diarrhoea.Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.Irritable bowel syndrome, the microbiota and the gut-brain axis.Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis.Irritable Bowel Syndrome and Stress-Related Psychiatric Co-morbidities: Focus on Early Life Stress.Postinfectious irritable bowel syndrome after travelers' diarrhea--a cohort study.High risk of post-infectious irritable bowel syndrome in patients with Clostridium difficile infection.Intestinal microbiota and the efficacy of fecal microbiota transplantation in gastrointestinal disease.Psychometric scores and persistence of irritable bowel after Campylobacter concisus infection.Exposure to environmental microbiota explains persistent abdominal pain and irritable bowel syndrome after a major flood.A randomized double-blind placebo-controlled trial of a multi-strain probiotic in treatment of symptomatic uncomplicated diverticular disease.Therapeutic Effects of Low-dose Bismuth Subcitrate on Symptoms and Health-related Quality of Life in Adult Patients with Irritable Bowel Syndrome: A Clinical Trial.Irritable bowel syndrome in children: Current knowledge, challenges and opportunities.Sexual dimorphism in bacterial infections.Post-infectious IBS: Defining its clinical features and prognosis using an internet-based survey
P2860
Q26777059-90DCF11B-74EA-4FF8-AE75-0DF8D9685E88Q26823844-A46DBA4D-8625-4ED8-A362-238AF7A9F44AQ26829363-4ADEBC95-C57D-42E6-AA5A-18E0C26BE456Q28074108-E0FB4D0D-D402-4A06-8B10-CF85DB9BB9FAQ28085584-9F1CA661-3407-43D5-9655-8EA32843F145Q28396111-5F1A82C5-3692-43AB-8F3B-A8035F77209BQ30424368-1C1957C6-18A9-4123-9C13-EEFA27A52B82Q33469255-67D9F82D-DAE7-498B-ADDB-6DC08D5EE863Q33661064-2E7BCE25-7A63-451E-8357-80C5F3B4BA03Q34366837-B9246513-9656-4BDD-B429-7D68171D0B64Q35039411-92C81E24-EE01-4433-AEE5-A82A6416D0CEQ35044211-B25CC75D-8155-4AD8-8F6E-B6966D2618B8Q35450209-A3DFCD4B-DD96-4DFC-913D-F44A75907109Q35723382-E2CBE3E4-C019-4802-8CDA-DF6E434FEB2EQ36144375-CA0D752B-4C94-42DC-AD6B-805332A9540DQ37234770-061E6A9D-105B-436B-9399-9476A040DC7EQ37629670-A0AF976A-2ACE-4AAB-8FF1-D3FDFB0ABCF8Q37715205-A5D54E12-F485-4F59-B91A-EA11495C5A81Q38179528-7F9740F9-D685-4545-9D7D-FC3D15B01381Q38420105-A3B4C7EC-8D9A-4716-8B76-609EDACADAC7Q38445280-1A6E9997-47B8-489A-8CAE-1BC85E81AB70Q38912505-9F26091C-E245-49E6-935F-E95C946BAA41Q39077262-BB57CB36-F31A-4611-A80A-5484613C1C65Q39148827-4F2B9122-EAAA-41EF-8E80-2DCF193E9674Q39441319-777E9969-08BD-49E4-904A-1E288A878F80Q40604510-2F957C21-1588-4C18-AD66-4E5CE0A64719Q41365278-78DD1E23-89A8-4877-AF49-FF524119CC1AQ42223268-7F2857DC-AB3B-4180-9D68-EF8C64E2D1F7Q47137141-78DE51B7-14DB-441E-B7A1-88C6EC2FEB6AQ54087826-57FD0796-2217-48D4-90CF-F747F2798F01Q54956782-DD02580E-E0A9-43F7-B0A2-08A419102B80Q55339881-A23D7AB7-EBDF-42FD-9BBA-8B0C1D76FF99Q55431367-6146C36A-0C11-481D-AF48-604E32557F6FQ57063253-DC0619BA-8F3B-4BC3-92D3-0DA58FB6300E
P2860
Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Postinfectious irritable bowel ...... h Salmonella or Campylobacter.
@en
Postinfectious irritable bowel ...... h Salmonella or Campylobacter.
@nl
type
label
Postinfectious irritable bowel ...... h Salmonella or Campylobacter.
@en
Postinfectious irritable bowel ...... h Salmonella or Campylobacter.
@nl
prefLabel
Postinfectious irritable bowel ...... h Salmonella or Campylobacter.
@en
Postinfectious irritable bowel ...... h Salmonella or Campylobacter.
@nl
P2093
P2860
P921
P1476
Postinfectious irritable bowel ...... h Salmonella or Campylobacter.
@en
P2093
A V Polster
I B Autenrieth
J Schwille-Kiuntke
S Klosterhalfen
P2860
P304
P356
10.1111/J.1365-2982.2011.01779.X
P577
2011-08-30T00:00:00Z